Bio-Rad Reports First-Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Bio-Rad Labs (BIO) Tops Q1 EPS by $2.21
April 29, 2021 4:18 PM EDTBio-Rad Labs (NYSE: BIO) reported Q1 EPS of $5.21, $2.21 better than the analyst estimate of $3.00. Revenue for the quarter came in at $726.8 million versus the consensus estimate of $660.98 million.
2021 Financial Outlook
For the full year 2021, the company has updated its guidance and now anticipates non-GAAP... More



